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Abstract 
Fibrosis is an incurable feature underlying chronic lung and airway diseases including chronic 
obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) that causes 
partial or total occlusion of the airway with fibrous tissue. In addition to causing these diseases, 
fibrosis also limits the effectiveness of lung transplants as a long-term treatment for end-stage 
diseases by causing the complication bronchiolitis obliterans syndrome (BOS). In order to 
improve our understanding of airway fibrosis, we have developed and characterized an in vitro 
cell co-culture model composed of airway epithelial cells and blood vessel endothelial cells 
through which we can induce fibrotic development. This model is more physiologically relevant 
than previous single cell-type monolayer cultures, as it features interaction between two cell 
types that are crucial in fibrotic stimulation and development in the airway. We propose a 3D 
transwell model featuring an air-liquid interface (ALI) as well as a 2D co-culture model with 
which cell phenotype-specific markers can be visualized with immunofluorescent microscopy. 
 
One step during the progression of fibrosis that can be visualized in this model is epithelial to 
mesenchymal transition (EMT), which is the shift of epithelial cells to a fibrotic mesenchymal 
cell-like state. Using the inflammatory cytokine TGFβ1, we are able to induce fibrotic EMT-like 
phenotypic changes in our 2D cell co-cultures marked by increased intensity in immunostaining 
for the mesenchymal marker vimentin. We were not able to observe a similar increased intensity 
for the mesenchymal marker FSP1, nor were we able to observe a reduced intensity for the 
epithelial marker E-cadherin that have been previously reported to correspond with EMT. 
Furthermore, we tested treatment of co-cultures with BMP7, an antagonist of EMT, at various 
points of EMT induction in attempts to reduce fibrotic development. We found that it is only 
effective in reversing EMT when added after TGFβ1 and can therefore only potentially be used 
as a post-treatment option. 
 
In this study, we (i) develop a co-culture model with increased physiological relevance to the 
airway, (ii) characterize effects of TGF-β1 cytokine-induced fibrotic EMT on this model of the 
airway epithelium, and (iii) characterize the ability of BMP7 to reduce fibrotic EMT when 
introduced at various time points in the initiation and development of fibrosis.  
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Introduction 
 
 Fibrosis is the progressive buildup of excessive tissue resulting from an exaggerated 
healing response to injury. Because it results from a complex network of signaling pathways, the 
root causes of many fibrotic disease states are unknown, especially in those that impact the 
respiratory system. To improve our understanding of fibrotic development in the airway, we 
designed a novel physiologically relevant co-culture model featuring epithelial and endothelial 
cells. Through this model, we induced fibrosis with the fibrogenic cytokine TGFβ1, which causes 
cells lining the airway epithelium to enter a more mesenchymal fibroblast-like phenotype. This 
change, known as epithelial to mesenchymal transition (EMT), is an important step in the 
development of fibrosis. Upon inducing fibrotic EMT in our model, we observed the effects of 
added factors like bone morphogenic protein 7 (BMP7) on fibrotic development in hopes of 
finding a potential treatment for irreversible fibrotic airway diseases like chronic obstructive 
pulmonary disorder (COPD) and idiopathic pulmonary fibrosis (IPF).  
The lungs are constantly exposed to the surrounding environment, making them the internal 
organ most susceptible to injury and infection from outside sources. Globally, it is estimated that 
at least 2 billion people are exposed to toxic fumes produced by the ineffective or poorly ventilated 
burning of biomass fuel and 1 billion people inhale outdoor air pollutants (Forum of International 
Respiratory Societies, 2017). Moreover, 1 billion people are exposed to tobacco smoke, which is 
listed by the World Health Organization (WHO) as one of the top five global risks for mortality. 
An individual’s prolonged exposure to any or all of these extrinsic factors can result in impairments 
of lung and airway function, ultimately leading to severe illness or death. As a result, lung disease 
poses a worldwide health burden that affects individuals from all social classes and backgrounds, 
although poor living conditions can dramatically exacerbate the vulnerability of resident 
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populations. The most prevalent of lung diseases are asthma and chronic obstructive pulmonary 
disease (COPD).  
COPD is an overarching classification for chronic diseases that cause airflow blockage 
such as emphysema and chronic bronchitis. It is a progressive condition in which small airway 
fibrosis gradually results in greater occlusion, rendering it increasingly difficult for patients to 
breathe naturally. Unlike asthma, this decreased airflow is not fully reversible, making COPD the 
third leading cause of death worldwide (Schluger and Koppaka 2014). More than 200 million 
people are affected by COPD, and of the 65 million people who have moderate to severe forms of 
the disease, an estimated 3 million die each year. While there is no cure available, treatment is 
effective in promoting improved quality of life during earlier stages of the disease. However, 
studies have shown that it is misdiagnosed or undiagnosed by 72 to 93%, resulting in delayed 
treatment (Forum of International Respiratory Societies, 2017). Thus, it is imperative for 
researchers to study COPD and its related afflictions, particularly since its mortality rate is 
predicted to rise, especially in Asia and Africa, as tobacco use continues to increase globally.  
Another fibrotic lung disease is idiopathic pulmonary fibrosis (IPF), which is characterized 
by fibrotic tissue accumulation and excessive collagen deposition in the alveoli as the result of an 
unknown cause (Kim, Kugler et al. 2006). It is estimated that 90 thousand adults in the US have 
IPF and 35 thousand individuals are diagnosed with it every year (Raghu, Weycker et al. 2006). 
Because little is known about how IPF is initiated or progressed, adequate diagnostic guidelines 
cannot be instated, and no cure is currently available. As a result, the median survival in patients 
is only 3 to 5 years, with over 80% of these fatalities attributed to respiratory failure (Schwartz, 
Helmers et al. 1994). Because rapid deterioration requiring hospitalization in about 35% of patients 
(Song, Hong et al. 2011) and high mortality rates are common in this condition, the persisting lack 
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of understanding of its underlying causes and the inability to procure a cure render IPF a condition 
that merits further study. 
Fibrosis is not only an underlying problem in lung diseases but is also a complication that 
reduces the effectiveness of treatment for these conditions. One of the few long-term treatments 
for end-stage lung diseases like COPD and IPF is lung transplantation, which significantly 
improves patient quality of life. However, the five-year survival rate of the limited number of 
recipients is below 50%, primarily due to the bronchiolitis obliterans syndrome (BOS) (Estenne 
and Hertz 2002). Symptoms include decreased forced expiratory volume per second (FEV1), 
indicating reduced lung function resulting in decreased activity endurance and shortness of breath. 
In BOS, inflammation in the lungs results in partial or total occlusion of the small airways by 
fibrous tissue. Unfortunately, pharmacologic agents have been unsuccessful in countering the 
progression of BOS, resulting in life-threating states of significantly impaired airflow. Thus, 
despite advances in surgical technique and postoperative care, progressive obstruction of airways 
because of fibrosis prevents long term success of most transplants. Because of the severity of all 
its clinical presentations, we used the physiologically relevant co-culture airway models designed 
in this study to characterize the initiation, progression, and potential reduction of fibrosis. 
One of the causes of fibrosis leading to the deposition and accumulation of fibrous tissue 
is an exaggerated healing response stimulated by chronic inflammatory signals. In the 
aforementioned conditions of COPD, IPF, and BO, airway remodeling has been suggested to play 
a key role in disease presentation and progression. Changes in airway structure are a natural 
response to inflammation and irritation, allowing fluids, proteins, and inflammatory cells to move 
from the microvasculature into the interstitial tissue (Busse, Elias et al. 1999). In the presence of 
chronic inflammatory stimuli, however, tissue repair mechanisms become uncontrolled, triggering 
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an excessive fibroblastic response which forms of an expanded vascular bed and increases 
extracellular matrix collagen deposition. This leads to remodeling of airway tissue and structure, 
obstructing it over time.  
Epithelial to mesenchymal transition (EMT) is a key step in the initiation and progression 
of fibrosis in most tissues, including the airway modeled in this study. EMT is considered to be 
the point of intersection between inflammatory stimulation and fibrotic tissue accumulation. It is 
in this process that epithelial cells respond to inflammatory stimuli by changing their shape and 
altering their phenotypic properties such that mesenchymal markers are upregulated (López‐
Novoa and Nieto 2009). Because EMT is so critical in the development of fibrosis, it probably 
also initiates fibrosis in the lung and airways in response to inflammatory signals. Similar 
interstitial fibrotic development observed in kidney transplants has been partially attributed to the 
EMT pathway, in which proximal tubular epithelial cells shift towards a mesenchymal-like 
phenotype (Wang, Divanyan et al. 2018). This transformation is marked by cellular morphological 
changes and increased release of pro-fibrotic mediators, thereby promoting the development of 
chronic fibrosis, as is seen in COPD and IPF. Therefore, not only is EMT likely one of the 
underlying causes of a fibrotic lung diseases, but it also limits the effectiveness of lung transplants 
as long-term treatments for end stage lung diseases due to complications like BOS. 
Current in vitro models have established that introducing the fibrogenic cytokine TGF-β1 
induces EMT. More recent findings have shown that treatment with bone morphogenic protein 
(BMP)-7 has the potential to reduce these fibrotic changes by inducing the reverse process, 
mesenchymal to epithelial transition (MET) (Zeisberg, Hanai et al. 2003). The presence of 
mesenchymal fibroblast specific protein 1 (FSP1) markers in clinically stable lung allograft 
recipients demonstrates that EMT-generated fibroblasts are part of the wound-healing process in 
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lung transplantation (Ward, Forrest et al. 2005). This parallels the more commonly studied roles 
of EMT-generated fibroblasts in kidney transplant and cancer. Furthermore, excessive EMT has 
been associated with dysregulated epithelial repair, which contributes to fibrotic lung disease and 
BO (Borthwick, McIlroy et al. 2010). However, current in vitro two-dimensional models that 
feature only one cell type are limited by their inability to accurately represent lung epithelial 
physiology. A cell culture system which co-cultures bronchial epithelial cells (EP) with endothelial 
cells (EC) is one method to better model EMT induction and reduction in bronchial epithelium.  
In this study, we aim to (i) characterize a simplified but physiologically relevant model of 
the airway consisting of bronchial epithelial cells and vascular endothelial cells, (ii) elucidate the 
effects of TGF-β induced EMT on this airway model, and (iii) characterize the effects of BMP-7 
on reducing fibrotic development caused by TGF-β. In order to develop and understand this model, 
it is important to first consider the normal physiology of small airways, the role of EMT in tissue 
repair following injury and disease, as well as current models for each. 
 
 
Figure 1. Schematic diagram detailing cross-sectional layers of airway bronchi. Analyses of airway 
wall cross-sectional physiology demonstrated common cell layer distributions. (A) A gross horizontal 
cross-section of the airway reveals an innermost epithelium layer directly exposed to air in the lumen, a 
middle layer of collagen and smooth muscle, and an outermost adventitia layer that serves as the site of 
airway attachment to surrounding tissues. Figure from Kamm, 1999, courtesy of Cam Hrousis. (B) Upon 
closer investigation, the airway wall can be divided between the lamina propria and smooth muscle (as 
represented by the solid black line) into an upper and lower section, known as the mucosa and submucosa, 
respectively. Figure from Bai et al., 1994. 
A B 
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Small Airway Physiology 
 Structurally, the airways that compose the lung resemble an elaborately branched, inverted 
tree, where the trachea serves as the trunk and divides into two bronchi, which separate into smaller 
airway branches tipped with clusters of leaf-like alveoli. The bronchi are designated for airflow 
into smaller airways that end with membranous alveoli, the site of gas exchange. Early studies 
characterizing airway physiology divided the airway wall into several distinct layers that merely 
vary quantitatively in thickness and size between different branches of the lung (Bai, Eidelman et 
al. 1994).  
The epithelium is the innermost layer, which lines the lumen and is directly exposed to air 
from the surrounding environment [Figure 1A]. Directly beneath the epithelium is the basement 
membrane, followed by the lamina propria, a fibrous layer also referred to as the “subepithelial 
zone” containing blood vessels and connective tissue (Bai, Eidelman et al. 1994) [Figure 1B]. 
These three sections are grouped together as the mucosa, a site where cell migration is prominent 
during inflammation (Bousquet, Jeffery et al. 2000). Beyond the mucosa lies the submucosa, which 
includes another fibrous connective tissue layer, structurally supportive cartilage, and finally the 
adventitia, yet another connective tissue layer that anchors the airways to surrounding regions via 
parenchymal attachments (Kamm 1999). Within these described cross-sectional layers, each one 
serves an essential functional role. In this study, we are primarily interested in the endothelial and 
epithelial cells within the mucosa because of the heightened inflammatory cell activity localized 
in this site, which renders it of primary interest in developing models of chronic disease states. 
The release of inflammatory stimuli and response to these stimuli can be initiated by 
epithelial cells alone but may also be altered through cross-talk with neighboring endothelial cells. 
In the presence of inflammatory stimuli, inflammatory cells migrate through the endothelial lining 
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of blood vessels and accumulate diffusely across the airway walls and lungs. These same 
proinflammatory signals are essential to the development and sequential remodeling of the lung in 
utero (Cardoso 2001). The destruction of the parenchyma seen in COPD as a result of chronic 
exposure to inflammatory stimuli can therefore be viewed as examples of inappropriate airway 
remodeling, where the normal wound healing response associated with inflammation is 
exaggerated and becomes detrimental (Jeffery 2001). There has been an increasing interest in the 
direct role of epithelial cells in generating and mediating these inflammatory responses (Devalia 
and Davies 1993). For instance, recent studies have shown that the epithelium is deeply involved 
in mucosal inflammation, by enhancing innate and adaptive immune responses in the airways 
(Kato and Schleimer 2007). Researchers have also proposed endothelial and epithelial cells each 
play important roles in generating chronic disease-inducing inflammatory responses. Together, 
these two cell types exchange soluble factors, initiating a cross talk that further directs the resulting 
inflammatory response (Mögel, Krüger et al. 1998). Thus, it is imperative to identify the properties 
of the airway epithelium and endothelium cultured both in isolation and in co-culture, the latter of 
which is accomplished in this study. 
Previous works have extensively characterized the airway epithelium by culturing 
bronchial epithelial cells on their own in various in vitro, two-dimensional monolayer models. 
These culture methods include a plethora of cell lines, grown on solid surfaces such as standard 
cell culture plates, on permeable membranes, submerged in media, or at an air-liquid interface 
(ALI), where cells are exposed to growth-sustaining media on their basolateral side and air on their 
apical side (Bhowmick and Gappa-Fahlenkamp 2016). These techniques allow for a step-wise 
improvement in recapitulating key features of lung physiology, leading to the development of 
three-dimensional models featuring epithelial cells embedded in matrix-like scaffolds. However, 
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these models are still limited, as they focus solely on in vitro study of one cell type out of the many 
that participate in the inflammatory response.  
To address this issue, we can improve the physiological relevance of the monoculture 
model by introducing another cell type into the system. In this case, endothelial cells were used 
due to the potential for EP-EC cross-talk described earlier. These culture models also display a 
wide range of conditions. The simplest of these include a solid-surfaced cell-culture plate 2D 
culture (Zani, Indolfi et al. 2010). On the other hand, the most complex feature permeable 
membrane Transwell cultures at ALI with various arrangements of epithelial and endothelial cells 
along the Transwell membranes and corresponding culture plate wells (Mögel, Krüger et al. 1998, 
Hermanns, Unger et al. 2004, Zani, Indolfi et al. 2010, Sellgren, Butala et al. 2014). These models 
are the starting point for our model which will be used to study the impact of endothelial-epithelial 
















Figure 2. EMT can be divided into three main 
types, each with its own distinct timing and 
function. While all types of EMT involve the 
phenotypic shift of epithelial cells into mesenchymal 
ones, various forms of it exist in different tissues and 
at various points of an individual’s lifecycle. (A) Type 
1 EMT is implicated in development, where the 
formation of the trophoblast involves a phenotypic 
shift of the epiblast layer to generate the subsequent 
primary mesenchyme. (B) Type II EMT is 
characteristic of the wound healing response 
stimulated by inflammation. When prolonged, it can 
result in fibrotic development within inflamed tissues 
and their overarching organs. (C) Type III EMT is 
prevalent in cancer development, where epithelial 
cells in localized tumors can become dangerously 
motile by assuming a mesenchymal state, allowing for 
the metastatic progression of disease. Figure from 
Kalluri and Weinberg, 2009. 
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Epithelial to Mesenchymal Transition 
Epithelial to mesenchymal transition is defined as the biochemically driven shift in 
phenotype from stationary epithelial cells to migratory mesenchymal-like cells. This process is 
dependent on epithelial cell plasticity, the ability for individual epithelial cells to transition 
between phenotypes. While EMT has been understood to play an important role in development, 
it can also be observed in adults. During development, a phenomenon categorized as Type I EMT 
takes place, where the formation of the trophoblastic germ layers involves an EMT shift from 
epiblasts into the primary mesenchyme [Figure 2A] (Kalluri and Neilson 2003). However, another 
type of EMT that can be observed during adulthood and has gained more traction in recent years 
is Type III EMT, which confers metastatic properties to cancerous tissue. Localized epithelial cells 
in tumor growths undergo this change and develop into invasive mesenchymal cells, which can 
propagate metastases and cause life-threatening progression of cancerous states [Figure 2C] 
(Kalluri and Weinberg 2009).  
To further build on the foundational understanding of this biochemical phenomena 
thoroughly studied in Types I and III EMT, our work will focus on Type II EMT, in which 
abnormal, uncontrolled wound healing processes cause fibrotic changes in epithelial cells [Figure 
2B]. This form of EMT is induced following injury via inflammatory signals, such as growth 
factors, and results in increased secretion and build-up of extracellular matrix (ECM) (Kalluri and 
Weinberg 2009). While these changes occur to varying degrees across a population of cells, 
allowing for a spectrum of “partial EMTs”. Over time, continued exposure to inflammatory stimuli 
results in the migration of EMT-induced epithelial cells from their normal static epithelial layer. 
These cells move into the basement membrane and underlying tissue, where they may lose their 
epithelial  
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markers completely and display a fully fibroblastic phenotype instead, leading to the buildup of 
fibrotic tissue (Okada, Strutz et al. 1996).   
Fibrotic type II EMT has been studied in multiple organ systems and diseases, including 
the mouse models of kidney, liver, lung, and intestines. It is defined as the shift from an epithelial 
state to a mesenchymal state, which is also correlated with decreased epithelial cell markers like 
E-cadherin, and increased mesenchymal cell markers such as vimentin and fibroblast-specific 
protein 1 (FSP1) (Bartis, Mise et al. 2014). Introducing the inflammatory cytokine TGFβ to in 
vitro cell cultures induces similar cellular changes in morphology and cell-specific protein 
expression as Type II EMT. As a result, because both TGFβ addition and EMT induction result in 
the same cellular changes, we can conclude that TGFβ is able to induce EMT in cell cultures 
[Figure 3] (Chen, Yang et al. 2017).  
Bone morphogenic protein 7 (BMP7) is a protein that has been shown to have an 
antagonistic effect on fibrotic EMT development. More specifically, the addition or 
overexpression of BMP7 has been hypothesized to result in reduced fibrotic tissue development in 
inflammatory environments (Zeisberg, Hanai et al. 2003, Kinoshita, Iimuro et al. 2007). One 
Figure 3. Type II EMT is a progressive change in 
phenotype and corresponding cell surface markers 
from an epithelial to mesenchymal state in response 
to inflammatory stimuli. Epithelial cells can be 
induced to undergo EMT as an inflammatory response 
triggered by the release of molecules such as TGFβ 
following injury. When inflammatory signaling is 
prolonged, the conference of mesenchymal properties 
to the epithelium allows it to gain motility and migrate 
into the basement membrane and build up as excessive 
connective tissue customary in fibrotic disease. This 
gradual shift is accompanied by a change in prevalence 
of cell phenotype-specific surface markers such as a 
decrease in epithelial E- Cadherin and increase in 
mesenchymal vimentin. Figure from Bartis et al (2014). 
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limitation of these studies was the focus on the induction and progression of EMT in EPs alone in 
2D culture, which does not recapitulate in vivo conditions. This study uses the addition of 
endothelial cells to the EP culture to characterize the effect of multicellular cross-talk in TGF-β 
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Materials and Methods 
Cell Culture  
Rat aortic endothelial cells (RAOEC) (Sigma-Aldrich) were maintained in Rat Endothelial Cell 
Growth Medium (Sigma-Aldrich). Rat primary bronchial epithelial cells (RBEPC) (Cell Biologics) 
were maintained in Epithelial Cell Medium (Cell Biologics) supplemented with 0.5 mL Insulin-
Transferrin-Selenium (ITS), 0.5 mL epidermal growth factor (EGF), 5.0 mL L-Glutamine, 5.0 mL 
Antibiotics-Antimycotic Solution, and 10.0 mL Fetal Bovine Serum (FBS). Different cell types 
were cultured separately at 37°C and 5% CO2 until introduction into a co-culture system.   
 
3D Transwell Co-Culture. RAOEC and RBEPC were cultured on opposite sides of a translucent 
high-density polyethylene terephthalate (PET) transwell membrane insert (12 mm in diameter, 0.4 
μm pore size) (Corning), in which the top of the membrane was referred to as the apical surface, 
and the bottom of the membrane was the basolateral surface [Figure 4A]. Endothelial cells were 
cultured on the basolateral surface and epithelial cells were cultured on the apical surface for two 
weeks. The corresponding growth medium was added to each membrane-separated compartment 
and changed every two days unless an air-liquid interface was established, at which point the 
epithelial media in the apical compartment was removed for the remainder of the culture period. 
Cell Seeding. Transwell inserts were inverted such that the basolateral face of the membrane faced 
upwards. RAOEC in suspension were seeded as a single 200 μL drop onto the center of this surface 
at a density of 5 x 105 cells per cm2. RAOEC-seeded transwell membrane inserts were incubated 
for 2 hours at 37°C and 5% CO2 to allow time for the cells to adhere to the membrane surface. 
After this incubation period, 1.5 mL of endothelial growth medium was added to the basolateral 
compartment in the well plate. The media and cells in suspension that remained on top of the 
membranes were aspirated, and the inserts were placed in their normal orientation into the wells.  
RBEPC suspended in epithelial cell medium were seeded in a similar manner as the RAOEC. A 
single 200 μL drop was placed on the center of the apical surface at a density of 2.5 x 105 cells per 
cm2. Inserts were again incubated for 2 hours at 37°C and 5% CO2 to allow for cell adherence to 
the membrane. After this, the remaining media and cells were aspirated from the apical 
compartment, and 0.5 mL of epithelial cell media was added to maintain the cells.  








Establishing an Air-Liquid Interface (ALI). An air-liquid interface (ALI) in which only the 
endothelial cells are immersed in media while the epithelial cells are exposed to air was established 
by removing the epithelial cell media from the apical compartment [Figure 4B]. This was done on 
day 4, 7, or 11 of the two-week co-culture, and cells were compared to negative controls in which 
no ALI was established in the co-culture. 
 
2D Co-Culture. RAOEC were either seeded one day prior to or simultaneously with RBEPC on 
0.1% gelatin-coated 24-well tissue culture polystyrene cell culture plates. RAOEC were seeded at 
a density of 5 x 103 cells per cm2 and RBEPC were seeded at a density of 2.5 x 103 cells per cm2. 
Cells were co-cultured for either 4 or 7 days in a 1:1 mixture of epithelial and endothelial growth 
medium before experimental treatment. At this point, cells were cultured in regular media or media 
containing TGFβ (2 ng/mL or 5 ng/mL) or BMP7 (100 ng/mL) (R&D Systems) reconstituted in 
0.1% bovine serum albumin (BSA) in PBS and 4 mM HCl, for two days. In addition to studying 
the effects of TGFβ- or BMP7-containing media in comparison to regular media, we also studied 
the effect of adding both sequentially to the culture at different time points. For these experiments, 









Figure 4. Schematic of a 3D transwell co-culture of 
RAOEC and RBEPC featuring an air liquid interface 
(ALI). (A) Polyethylene terephthalate (PET) transwell 
membrane inserts were used to establish the co-culture. 
(B) RAOEC were cultured on the basolateral surface of 
the membrane, while RBEPC were cultured on the apical 
surface. Cells were maintained for two weeks with 
endothelial growth medium in the basolateral 
compartment and epithelial growth medium in the apical 
compartment. An ALI was established at day 4, 7, or 11 
of the co-culture by removing the apical epithelial growth 
medium. Figure (A) from Fisher Scientific and (B) 
modified from Oncotheis. 
 
B 
Figure 5. Schematic of TGFβ and BMP7 treatment in 
a 4-day 2D co-culture of RAOEC and RBEPC. ECs 
were added in isolation on the first day of co-culture 24 
hours before ECs were added on day 2. On day 4, medium 
was removed and only TGFβ, BMP7, or both were added 
to the medium (medium-only control not shown). On day 
6, only TGFβ or BMP7 were added to the same cultures 
they had been added to previously as controls or added to 
cultures they had not been introduced to before. On day 8, 
all cells were stained. 7-day cultures feature simultaneous 
addition of EPs and ECs on day 1, then treatment on days 
7 and 9, and fixation on day 11. 
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Immunofluorescent Staining and Imaging 
At the end of the co-culture period, cells were washed twice with PBS and fixed with 4% 
paraformaldehyde (PFA) in PBS for 15 minutes. Cells were then washed and permeabilized in 0.3% 
Triton X-100 in PBS for 10 minutes. At this point, cultures on transwell membranes were cut out 
from their inserts and gently transferred to 24-well plates containing PBS. Cells were washed again 
in PBS before they were blocked with 5% goat serum in 0.1% BSA in PBS for 45 minutes at room 
temperature. After blocking, cells were incubated at 4°C overnight with diluted primary antibodies 
in 0.1% BSA in PBS [Table 1].  
Endothelial cells were targeted by mouse CD31 (dilution=1:500, Abcam), epithelial cells 
with either mouse (dilution=1:250, Cell Signaling) or rabbit (dilution=1:2000, ThermoFisher 
Scientific) E-Cadherin, and mesenchymal cells with rabbit vimentin (dilution=1:1000, Abcam) or 
fibroblast-specific protein 1 (FSP1) (dilution=1:500, Abcam). Following another set of washes, 
primary antibodies were detected with corresponding secondary antibodies, which included 488- 
(dilution=1:2000, Cell Signaling), 546- (dilution=1:2000, Cell Signaling), or 647- conjugated 
(dilution=1:1000, Abcam) goat anti-mouse antibodies, and 488- (dilution=1:2000, Cell Signaling) 
or 594-conjugated (dilution=1:2000, Cell Signaling) goat anti-rabbit antibodies. Cells were 
incubated with secondary antibodies [Table 1] or with fluorescence protein conjugated primary 
antibody Alexa Fluor 594 Phalloidin (dilution=1:250, ThermoFisher Scientific) in 0.1% BSA in 
PBS in the dark at 4°C overnight, then washed. Nuclei were stained with DAPI (dilution=1 μg/mL, 
ThermoFisher Scientific) for 10 minutes in the dark.  
Transwell membranes were cut in half and mounted on glass slides such that the apical 
surface faced up on one half and the basolateral surface faced up on the other half. Coverslips were 
placed on the slides and allowed to dry before both sides of the permeable membrane filter were 
imaged. Fluorescence microscopy was performed at 25°C using a Leica DMI 6000 CS microscope 
with a Leica TCS SP5 II confocal scan unit (Leica Microsystems, Wetzlar, Germany) and a 
100x/NA 1.44 Plan Apo lens (Leica). A helium-cadmium laser (442nm), argon laser (488 nm at 
20% laser power output), or helium-neon laser (594nm and 647nm at 33% laser power output) was 
used for exciting fluorophores.  
2D cell culture plates were imaged using a Nikon Ti-E inverted epifluorescence 
microscope with 10x and 20x lenses. 
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Table 1. Primary and secondary antibodies used in immunofluorescence stains.  
Cell Phenotype Primary Antibody (Dilution) Secondary Antibody (Dilution) 
All Cells DAPI   
Phalloidin (1:250)  
Endothelial cells (EC) m CD31 (1:500) 488-conjugated Gαm (1:2000) 
546-conjugated Gαm (1:2000) 
647-conjugated Gαm (1:1000) 
Epithelial cells (EP) m E-Cadherin (1:250) 
Rb E-Cadherin (1:2000) 488-conjugated GαRb (1:2000) 
594-conjugated GαRb (1:2000) Mesenchymal cells  Rb Vimentin (1:1000) 
Rb Fibroblast-specific protein 1 
(1:500) 
 
Note:   m = mouse 
Rb = rabbit           
G = goat           
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Results 
 In this study, we designed a more physiologically relevant co-culture model of the airway 
featuring both endothelial and epithelial cell types. We then characterized the model by using 
immunofluorescence microscopy to visualize the phenotypic changes following inflammatory 
cytokine TGFβ-induced EMT in epithelial cells. Furthermore, using the same techniques, we 
characterized whether BMP7 reduces these changes when introduced at various time points of the 
EMT-induction process, notably before, simultaneously, or after TGFβ addition.  
 
Establishing a 3D Transwell Co-Culture  
 We established a three-dimensional Transwell membrane model with bronchial epithelial 
cells on the apical surface of the membrane and vascular endothelial cells on the basolateral surface 
as a physiologically relevant model of the airway [Figure 4B]. The airway is essentially a multi-
layered tube through which air travels, thus, a physiologically relevant in vitro model includes not 
only multiple cell types arranged in 3D layers, but also an air-liquid interface (ALI) in which one 
layer of cells is exposed directly to air and nourished by cells in an adjacent layer. The transwell 
insert model adequately meets this description, since it features 3D cell growth on both surfaces 
of a porous membrane suspended within a co-culture dish. Moreover, an air-liquid interface can 
be established by removing the media from the apical compartment, exposing the epithelial cells 
to air and allowing them to be maintained by the medium-immersed endothelial cells on the 
basolateral surface.  
 To test the viability of cells in this 3D model, we cultured rat bronchial epithelial cells 
(RBEPC) and rat aortic endothelial cells (RAOEC) on Transwell membrane inserts for two weeks 
as described above with RBEPC on the apical surface and RAOEC on the basolateral surface. To 
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determine the length of time epithelial cells could grow and survive with an ALI in this two-week 
culture period, epithelial cell growth medium was removed from the apical compartment on day 
4, 7, or 11 of the co-culture and compared to cell cultures in which medium was not removed and 
ALI was not created. After two weeks of culture, cells were fixed, stained, and mounted on glass 
slides to be imaged via confocal microscopy.  
 Stains for cell nuclei (DAPI) and actin (phalloidin) revealed that RAOEC and RBEPC cell 
layers were present on both apical and basolateral surfaces at all time points ALI was established 
(Day 4, 7, or 11), if at all [Figure 6]. Visualization of these cell structures indicated that not only 
were medium-immersed endothelial cells maintained successfully in this co-culture model for two 
weeks, but that epithelial cells were also maintained successfully through interactions with 
endothelial cells on the opposite side of the transwell membrane. Cell structure did not appear to 
be altered in the presence or absence of ALI, although greater amounts of actin appeared to be 
present at longer exposure to ALI in epithelial cells.  
While nuclei and microfilaments could be vividly observed in both cell layers, epithelial 
and endothelial cell-specific markers (CD31 and E-cadherin, respectively) could not be similarly 
visualized via immunofluorescent staining due to high background noise from the transwell 
membrane (Data not shown). Because these markers did not show a strong enough signal, we could 
not continue with this model for subsequent studies with TGFβ and BMP7, as these experiments 
are dependent on observing presentation of cell-specific markers. As a result, the limited success 
in staining for endothelial, epithelial, and mesenchymal markers in the transwell system rendered 
it unsuitable for this study despite its appeal as a more physiologically relevant representative 
model.  
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Figure 6. An air liquid interface (ALI) can be successfully 
established at Days 4, 7, or 11 of transwell membrane co-
culture. RAOEC P6 were maintained for two weeks in 
endothelial growth medium on the basolateral surface of a PET 
transwell membrane. RBEPC P6 were maintained in epithelial 
cell growth medium on the apical surface unless ALI was 
established at days 4, 7, or 11, at which point the epithelial 
medium was removed for the remainder of the 14-day culture 
period. At the end of two weeks, cultures were fixed, 
permeabilized, and immunostained for phalloidin (red) and 
nuclei (blue). Images captured via confocal microscopy revealed 
confluent cell growth on both surfaces, suggesting that ALI can 
successfully be established at day 4, 7, or 11 and maintained 
until the end of a 14-day culture. 
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Establishing a 2D Co-Culture 
 
 Because the transwell membrane of the 3D co-culture demonstrated a large degree of 
background noise preventing immunostaining for the cell-specific markers CD31, E-cadherin, and 
vimentin (data not shown), removal of the membrane from the co-culture resolved this problem. 
Despite the loss of the membrane-facilitated 3D layered structure and ALI, a 2D co-culture model 
featuring both epithelial and endothelial cell types retains improved physiological relevance in 
comparison to a single cell monolayer culture. We developed a 2D model where vascular 
endothelial cells and airway epithelial cells were cultured at a 2:1 ratio on 24-well PET tissue 
culture plates.  
 RAOEC and RBEPC successfully populated this 2D model. Both cell types were 
simultaneously added to a co-culture system which was then maintained for 7 days in 1:1 
endothelial and epithelial cell growth media prior to fixing, immunostaining, and imaging via 
fluorescence microscopy. Immunofluorescent stains for the endothelial cell surface marker CD31 
and the epithelial cell surface marker E-cadherin revealed that the endothelial cells were 
sporadically dispersed throughout a dense epithelial cell layer [Figure 7A]. Furthermore, all cells 
displayed one stain, for either CD31 or E-cadherin, not both or neither of the two stains. As a result, 
we confirmed that all cells in the co-culture were either ECs or EPs, and that cells not stained 
positively for endothelial markers like CD31 must be EPs, and vice versa.  
Reducing the culture time for this model further improved the model by improving the 
clarity of stains by reducing background signal from underlying cells. The tile-like pattern 
outlining patches of epithelial cell membranes was visible in the 7-day co-culture immunostaining 
for membrane-bound E-cadherin [Figure 7A, EPs arrow]. Beyond 7-days, the relatively long 
culture time caused cells to proliferate in layers on top of one another in different planes of view.  
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Figure 7. Endothelial cells integrate and form islands in 2D co-culture with epithelial cells. Endothelial 
cells (ECs) and epithelial cells (EPs) were added simultaneously into a tissue culture flask at a 2:1 ratio. This co-
culture was maintained for 7 days, after which cells were fixed, immunostained, and imaged with an inverted 
epifluorescence microscope. (A) Immunostaining for endothelial cell CD31 (red), epithelial cell E-cadherin 
(green), and nuclei (blue) showed that all the cells in the culture were either endothelial or epithelial cells. As a 
result, cells that did not stain positively for CD31 were epithelial. (B) ECs stained for CD31 (green) were 
integrated and dispersed throughout the extremely dense network of total cells (actin in red) present in the co-
culture. (C) CD31-stained ECs (green) formed islands when allowed to grow in the culture system 24 hours 
before EPs were added at a 2:1 ratio (ECs: EPs). A shorter co-culture time of 4 days also resulted in reduced 
overall signal, as cells were not as densely layered (actin in red). Scale bars: 100 μm.  
 
This rendered it difficult to capture images in which most cells were in focus, which was resolved 
by reducing the culture time to 4 days. The reduction in cell density was accompanied by less 
intense staining for general cell structures like nuclei and actin filaments, reducing overall signal 
and allowing for improved observation of individual cell morphology [Figure 7C].  
Introducing ECs to the system 24 hours prior to EPs allowed for the formation of 
physiologically relevant EC island structures within the co-culture. The 7-day co-culture revealed 
that despite being introduced in larger quantities, ECs proliferated less readily than their EP 
counterparts within the co-culture system. Immunostaining for endothelial CD31-positive cells 
showed that ECs were often isolated and dispersed throughout dense cell layers [Figure 7B]. In 
the airway, individual vascular ECs interact not only with the airway epithelium, but also with 
other adjacent ECs, which was not represented in our 2D model. To rectify this, we seeded the 
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ECs  24 hours before the EPs at the same 2:1 ratio, as we reasoned the presence of independent 
ECs to be due to their intrinsically slower proliferation rate in comparison to EPs. Because they 
grew more slowly, we hypothesized that they were restricted by the EPs when simultaneously 
introduced to the culture and the ECs were not able to proliferate in larger groups. Staining for 
CD31, nuclei, and actin in 2D models cultured for the reduced 4-day period confirmed that adding 
RAOECs on their own to the tissue culture plates 24 hours before adding RBEPCs led to the 
formation of EC clusters or islands [Figure 7C].  
These results suggest that the more physiologically relevant 2D model of those that we 
developed and tested featured not only both EC and EP cell types, but also a lower overall density 
of cells and the presence of endothelial cell islands. This was successfully accomplished by 
reducing the co-culture time from 7 days to 4 days and adding ECs to the system 24 hours prior to 
introducing EPs to the system rather than simultaneously.  
 
TGFβ-Induced EMT 
 Using our 2D in vitro co-culture model of the airway, we observed the effect adding TGFβ 
to the system has on the epithelial cells. We hypothesized the addition of TGFβ would induce an 
epithelial to mesenchymal (EMT) phenotypic shift in RBEPC cell-specific marker expression 
similar to that seen in previous studies of epithelial cell monolayers (Zeisberg et al., 2003). As a 
result, we hypothesized that if EMT was successfully induced with TGFβ, the co-cultures would 
display less intense positive staining for the epithelial cell-specific marker E-cadherin and more 
intense immunostaining for the mesenchymal cell markers vimentin and fibroblast-specific protein 
1 (FSP1).  
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Figure 8. Stain intensity of mesenchymal and epithelial cell markers is altered in TGFβ-induced EMT. 
After 7 days of EC/EP co-culture, TGFβ (5 ng/mL) was added to the medium and cells were maintained for 
another 48 hours and then fixed, immunostained, and imaged. (A – B) Immunostaining for mesenchymal cell 
vimentin (red), epithelial cell E-cadherin (green), and nuclei (blue) showed that all cells stained positively for 
vimentin. However, TGFβ-treated cells displayed more intense vimentin stains. (C – D) Mesenchymal FSP1 
(red) stained fewer cells (nuclei in blue) and was therefore more specific than vimentin. FSP1-positive stains 
were more intense in the control than in the TGFβ conditions. E-cadherin (green) staining was more intense and 
produced more background noise in the latter. (E – F) Addition of TGFβ (5 ng/mL) for 48 hours to a less densely 
populated 4-day co-culture model of ECs an EPs (nuclei in blue) showed increased vimentin (red) stain intensity 
and reduced E-cadherin (green) stain intensity. Scale bars: 100 μm.  
 
 In the 7-day culture model where EPs and ECs were introduced at the same time, TGFβ (2 
ng/mL or 5 ng/mL) was added at either a higher or lower concentration to the medium (1:1 
epithelial to endothelial growth medium) on day 7 of the co-culture. Cells were maintained in this 
TGFβ-medium for 48 hours before they were fixed and immunostained for nuclei, the epithelial 
cell marker E-cadherin, and either the mesenchymal marker vimentin or FSP1. Images captured 
via immunofluorescent microscopy revealed that intracellular vimentin was present in all cells, 
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even endothelial cells, although the stain intensity was brighter in cells treated with higher 
concentrations of TGFβ in comparison to control cells cultured in media only [Figure 8A-B]. The 
intensity of the stain in both experimental and control groups also appeared to overpower the 
membrane-localized epithelial cell E-cadherin stain. No noticeable difference was seen in stain 
intensity in cells treated with lower concentrations of TGFβ [Figure 9A-B]. 
A 4-day culture model where ECs were added 24 hours before EPs confirmed the increased 
intensity of vimentin staining in response to treatment with TGFβ [Figure 8D-E]. Co-culture 
systems were maintained for a total of 4 days, with endothelial cells only were introduced on day 
1 and epithelial cells were added to the culture on day 2. A higher concentration of TGFβ (5 ng/mL) 
was tested in this model, which promoted even more dramatic effects that were seen more clearly 
in the less densely populated cell sheet. In support of our hypothesis, as the intensity of vimentin 
staining increased with the addition of TGFβ, the intensity of E-cadherin was reduced, showing an 
inverse relationship. Thus, in both 4- and 7-day models, increased presence of vimentin and 
decreased presence of E-cadherin suggested EMT can be successfully induced by TGFβ. 
Immunostaining for FSP1 demonstrated more specificity for mesenchymal-like cells, as 
fewer cells were positively stained, which allowed for better visualization of E-cadherin staining. 
The intensity of FSP1-positive stained cells in the culture, however, seemed to be comparable to 
or even slightly lower in the TGFβ-treatment group relative to the control group [Figure 8B-C]. 
Conversely, staining for epithelial E-cadherin was more intense in the TGFβ-treatment group 
compared to the control group. However, these E-cadherin stains did not include the tile-like 
pattern outlining epithelial cell membranes. Because the FSP1 immunofluorescent staining results 
were contrary to both our expectations and the vimentin staining results, both mesenchymal 
markers merited further characterization within our 2D model of airway EMT. 
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Figure 9. Addition of BMP7 following TGFβ-treatment of cells reduces EMT-like phenotypic change in 
epithelial cells. After 7 days of EC/EP co-culture, BMP7 (100 ng/mL) was introduced at various time points of 
TGFβ-induced EMT (2 ng/mL). BMP7 was added (D) 48 hours before TGFβ, (E) simultaneously with TGFβ, 
or (F) 48 hours after TGFβ. Control sample cultures were treated with (A) only media, (B) only TGFβ, or (C) 
only BMP7 at day 7 of co-culture and maintained for 48 hours. Immunostaining for mesenchymal cell vimentin 
(green), epithelial cell E-cadherin (red), and nuclei (blue) showed that all cells stained positively for vimentin. 
Vimentin stains appeared comparable in all three of these control groups while E-cadherin displayed an increased 
intensity with TGFβ or BMP7 treatment. Only treatment with BMP7 for 48 hours after TGFβ displayed notable 
reduction in vimentin stain intensity and increased E-cadherin stain intensity. Scale bars: 100 μm.  
 
 
Reduction of EMT with BMP7 
 
 The successful induction of EMT-like change by TGFβ within our 2D co-culture model 
led us to consider whether treatment with BMP7 would reduce the EMT-invoked phenotypic 
changes caused by TGFβ, as shown in previous single cell type monolayer cultures (Zeisberg et 
al., 2003). Furthermore, we asked whether this reduction or partial reversion of EMT by BMP7 
was time-dependent; that is, does the time at which BMP7 was added in the EMT-induction 
process affect TGFβ’s ability to reduce EMT? To test this experimental question, we added BMP7 
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(100 ng/mL) to 2D endothelial-epithelial cell co-culture systems 48 hours prior to the addition of 
TGFβ, concurrently with TGFβ, or 48 hours after the addition of TGFβ. Cells were fixed, 
immunostained for nuclei, epithelial cell E-cadherin, and mesenchymal cell vimentin or FSP1. 
Intensity and localization of stains for cell-specific markers were compared to control co-cultures 
in which only TGFβ, BMP7, or growth medium were added for 48 hours. 
 At lower concentrations of TGFβ (2 ng/mL), control treatments of cells with only medium, 
TGFβ, or BMP7 displayed comparable vimentin-positive staining intensities [Figure 9A-C]. 
Despite this observation, E-cadherin staining was more intense in the TGFβ-treated group, 
followed by the BMP7 only treatment, and the least intense in the medium-only control. Treatment 
with BMP7 48 hours prior to or simultaneously with the addition of TGFβ to the co-culture system 
did not demonstrate much change in intensity of vimentin or E-cadherin in comparison to the 
controls [Figure 9D-E]. Only when co-cultures were treated with BMP7 for 48 hours after being 
treated with TGFβ for 48 hours was the intensity of intracellular vimentin staining reduced [Figure 
9F]. While the E-cadherin staining subsequently appeared more intense, image analysis revealed 
that it remained comparable to the other conditions and only looked brighter because of the less 
intense vimentin stain.   
 More dramatic reductions in vimentin intensity were observed when cultures treated with 
BMP7 after a higher initial TGFβ concentration (5 ng/mL). When treated with higher 
concentrations of TGFβ for 48 hours on day 7 of co-culture, vimentin stains were slightly more 
intense than medium-maintained controls [Figure 10A]. BMP7 treatment before and during EMT 
induction generally displayed similar vimentin-positive intensities as the medium-only control 
apart from regions populated by clusters of bright vimentin-positive cells. The greatest difference 
in staining observed in our model was the cellular response to BMP7 added post-EMT  
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A – E-Cadherin (Green) and Vimentin (Red) 
B – E-Cadherin (Green) and FSP1 (Red) 
 
  31 
Figure 10. Addition of BMP7 following TGFβ-induced EMT decreases expression of mesenchymal cell 
phenotypic markers. EC/EP 2D co-cultures were treated with BMP7 (100 ng/mL) 48 hours prior to, 
simultaneously during, or 48 hours following introduction of TGFβ into the system. Cells were fixed and 
immunostained for nuclei (blue), epithelial E-cadherin (green), and either mesenchymal (A) vimentin or (B) 
FSP1 (red). Comparison to controls maintained in medium or induced with TGFβ showed that only cells treated 
with BMP7 after TGFβ had dramatically reduced expression of mesenchymal cell markers within the culture. 
This suggests that among all conditions tested, EMT was reduced the most only when BMP7 was added after 
TGFβ-induced EMT had already taken place. Scale bars: 100 μm. 
 
induction, in which most cells were not stained internally with vimentin, and only membranes 
were outlined by the stain. The same effects were observed for the mesenchymal cell marker FSP1, 
which was barely expressed in co-cultures treated with BMP7 after EMT was induced by TGFβ 
but was expressed in all other treatment groups [Figure 10B].  
Due to time constraints, we do not present data where BMP7 is introduced during the EMT-
induction process in the 4-day culture model, which could be advantagous in providing improved 
image clarity and reduced background noise. Measuring phenotype-specific marker expression 
within co-culture cell populations was also attempted using flow cytometry but was not successful 
since the cells could not be dissociated into a single cell suspension due to the adhesive nature of 
epithelial cells. 
Our results indicated that introducing BMP7 to the co-culture system after EMT is induced 
by TGFβ rescues epithelial cells from the mesenchymal phenotype by causing them to express 
fewer mesenchymal markers, though the intensity of epithelial markers may remain constant. This 
stark phenotypic shift indicated by the loss of vimentin and FSP1 staining suggested that order of 
induction by TGFβ and BMP7 is important in determining the net shift in epithelial to 
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Discussion 
 The present investigation proposes an epithelial-endothelial cell co-culture model system 
that improves limitations present in current models of fibrosis induced by the addition of the 
inflammatory cytokine TGFβ. Current models only feature one cell type in two-dimensional 
culture and are thus limited in their ability to represent the airway epithelium, which possesses 
multiple cell types and layers. In response to this, we designed and characterized more 
physiologically relevant 3D and 2D co-culture models of the airway featuring two key cell types 
present within the airway: epithelial and endothelial cells. Next, we applied the co-culture systems 
developed to study EMT-induced fibrotic change in vitro. Specifically, using the 2D co-culture 
model in which we could visualize cell type-specific markers with immunostaining techniques, we 
studied the phenotypic shifts in epithelial cells driven by TGFβ-induced EMT. Finally, after 
observing the effects of EMT within our cultures, we further characterized the ability of BMP7, a 
protein that induces the opposite phenotypic shift from mesenchymal to epithelial cell phenotype 
(MET), to reduce EMT within our culture model.  
Our findings demonstrate that EPs and ECs can be successfully cultured together in both 
3D ALI and 2D systems. However, for the purposes of studying EMT, the 2D co-culture is superior 
to the 3D co-culture despite the greater degree of physiological relevance presented by the latter. 
This is because we are able to visualize endothelial, epithelial, and mesenchymal cell-specific 
markers via immunofluorescent staining in the 2D co-culture model, but not in the 3D ALI model. 
As a result, we are only able to distinguish between different cell types and observe phenotypic 
shifts in epithelial cells after exposure to TGFβ, BMP7, or a combination of the two in the 2D co-
culture system.  
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2D co-cultures maintained for 4 days prior to treatment demonstrate the greatest degree of 
EMT transition when exposed to higher concentrations of TGFβ. This is marked by an increase in 
mesenchymal vimentin stain intensity, although epithelial E-cadherin intensity remains 
comparable. Lastly, we found that the ability of BMP7 to reduce EMT-driven phenotypic shift is 
dependent on when it is introduced in the EMT induction process. In particular, treatment with 
BMP7 only reduces intracellular vimentin stain intensity when added 48 hours after EMT is 
induced. This effect is not seen when co-cultures are pretreated with BMP7 for 48 hours before 
induction, nor when cells are exposed to BMP7 and TGFβ simultaneously. This suggests that 
BMP7 only has the capability to lessen the effects of EMT phenotypic change after fibrotic 
development has already begun and is likely not effective as a preventative pre-treatment 
administered prior to the induction of fibrosis. 
In the epithelial-endothelial co-culture models proposed, we are not only able to maintain 
cells in a more physiologically relevant system, but we can also characterize the phenotypic 
changes associated with fibrotic TGFβ-induced EMT. We use this in vitro representation of the 
airway to show that BMP7 can serve as a potential treatment for fibrosis only after it has developed 
and cannot be used to prevent fibrotic change in tissues. Furthermore, while our results focus on 
and raise follow-up questions regarding the interactions between TGFβ and BMP7 in EMT 
progression, our model can also be extended to test the impact of other drugs on airway fibrosis. 
Thus, further characterization, optimization, and development of the co-culture models described 
in this study would contribute to a heightened understanding of the molecular triggers and potential 
treatments for fibrotic type II EMT implicated in many airway diseases.  
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3D Transwell Co-Culture Model 
 The most physiologically relevant model of the airway examined in this study is a 3D 
transwell co-culture system that supports endothelial and epithelial cell growth on opposite sides 
of a porous transwell membrane [Figure 4B]. In addition to being successfully maintained for a 
relatively long-term culture period of two weeks, we found that this model system can also support 
an ALI established as early as 4 days into culture without adverse effects on EP vitality. Whether 
ALI can be established earlier than 4 days and what the minimum culture time prior to establishing 
ALI could not be extrapolated from our study and would require more characterization of the 3D 
transwell system to discern.  
Confocal images of nuclei and cytoskeletal actin filaments in both apical air-exposed 
epithelial cells and basolateral medium-immersed endothelial cells show that confluent cell layers 
are present regardless when ALI was established in this study (4, 7, 11, and 14 days) [Figure 6]. 
This suggests that in the absence of nourishment from the surrounding growth medium, air-
exposed EPs can be maintained through interactions with endothelial cells across the membrane. 
Direct parallels can thereby be drawn between our 3D transwell ALI model and gross airway 
physiology, since the airway epithelium is constantly exposed to air and is similarly sustained with 
materials provided by blood vessels lined with endothelial cells.  
 Our model implements a two-week cell culture period to allow for stabilization of the 
culture system after both cell types proliferate to reach confluence. To place this on a more 
physiologically relevant time scale, the airway epithelium turns over at a gradual by constant rate, 
renewing completely every thirty to fifty days in comparison (Bowden 1983). Confocal images 
taken at the end of the culture period demonstrate that ECs and EPs form confluent cell layers by 
the end of two weeks, but this was the only time at which cell growth was captured in this study. 
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While we would have liked to observe cells within the culture at more timepoints via phase contrast 
microscopy to better grasp the process of cell layer development and stabilization, we were not 
able to. Unlike previous works which were able to visualize epithelial cell layers grown on 
Transwell membranes using phase contrast microscopy (Janda, Nevolo et al. 2006), our inability 
to focus on and capture images of distinct cell layers may be attributed to the dual layer of cells 
our model featured. As a result, despite the transparent nature of the Transwell membrane that 
allows for observation of cell layers under phase contrast microscopy, the density of cells on both 
membrane surfaces may scatter light and prevent the adequate focus on cells situated on either 
side.  
 If the dense background of cells is what prevents observation of transwell EP/EC co-
cultures via phase contrast microscopy, then background noise from the membrane is what inhibits 
the visualization of immunostaining for cell-specific markers (data not shown). We found that 
transwell membranes mounted on slides only clearly stain positively for nuclei and filamentous 
actin, whereas cell phenotype-specific immunostaining displays nothing but noise from the 
transwell membrane itself with no distinct positive stains from the cell layers populating it. This 
not only prevents us from identifying cell phenotype via immunostaining, but also does not allow 
us to visualize and control for cell migration across the transwell membrane to the opposite surface, 
which is another common experiment transwell inserts are used for. A potential means by which 
this problem can be addressed, and immunostaining can be visualized regardless of the membrane 
background, is by embedding immunostained membranes in paraffin or agarose blocks. 2D cross-
sections of the co-culture system can then be produced by sectioning the blocks vertically, much 
like what is done with fixed tissue samples. These sections will present thin slices of cells 
populating both apical and basolateral membrane surfaces that can likely be imaged to reveal cell-
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specific proteins, although this would not allow for visualization of cell layer topography or cell 
morphology. 
In the interest of time, since this model is incapable of discerning cell phenotypes based on 
protein markers such as endothelial CD31 and epithelial E-cadherin, it was unfortunately 
discontinued in spite of its potential and its superior 3D ALI physiological relevance. This is 
because rather than developing and optimizing the 3D model, we were more intent on studying the 
biological phenomenon underlying fibrotic type II EMT development. Therefore, for our purposes, 
we continued forth using a 2D co-culture model in which we could observe cell-specific 
immunostained markers in subsequent studies to characterize EMT-like phenotypic shifts induced 
by TGFβ and to determine the potential for BMP7 to reduce these transitions.  
 
2D Co-Culture Model 
 Removal of the transwell membrane from the 3D co-culture in response to the high 
background noise stain reduces the model to a 2D co-culture of EPs and ECs that can be visualized 
using immunofluorescent staining. While doing so eliminates the potential for establishing 
distinctly separated cell layers or an ALI, this model retains increased physiological relevance in 
comparison to single-cell type monolayers due to the interaction it allows between multiple cell 
types within the culture. Stains for cell-specific markers demonstrate that cells in our culture do 
not express both epithelial and endothelial-specific proteins. Since no cells also express neither of 
the two markers, we can conclude that only EPs and ECs are present in our culture, and therefore 
that any cell not stained for an EC-specific marker like CD31 must be an EP. This enables us to 
distinguish between cell types and observe morphology simultaneously in our immunostaining 
assays by using one cell-specific marker alongside cytoskeletal actin stains for all cells. Essentially, 
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morphology of all cells can be visualized, and cells with an additional positive stain must be of a 
particular type; all other cells stained only with phalloidin must be the other type. 
Because RAOEC were observed to have longer proliferation rate and less efficient 
attachment to cell culture plates compared to RBEPC during the process of preparing both cell 
types for co-culture, they were added to the culture in a 2:1 ratio (ECs: EPs). When maintained for 
7 days, both cell types survive together in culture, forming a dense network of EPs with individual 
ECs incorporated sporadically amidst it [Figure 7A-B]. This implies that despite initially 
populating with culture with twice as many ECs as EPs simultaneously, the ECs do not fare as 
well in the co-culture. One explanation for this could be that because of the exceedingly fast 
proliferation rate of EPs, ECs are outcompeted for space and are therefore unable to form valuable 
cross-talk with cells of its own type in time before they are surrounded by EPs. Moreover, we 
discovered that the dense population of cells layered atop one another accumulates background 
noise when imaged, which renders it more difficult to focus on one layer of cells across the entire 
field and identify morphological changes. 
To compensate for the shortcomings of the 7-day model, we modified it such that the ECs 
are added to the system 24 hours prior to the EPs and reduced the total culture time to 4 days. 
Inserting ECs into the tissue culture plate in advance of EPs allots them a buffer time to attach, 
proliferate, and begin to populate the system without other competition. In addition, reducing the 
number of days of co-culture allows for a clearer visualization of the cells and tones down 
background noise by reducing cell density. We note that immunostaining of endothelial CD31 and 
epithelial E-cadherin in the 4-day co-culture displays ECs arranged in islands among EP networks, 
demonstrating that interactions between ECs is made possible in this modified model [Figure 7C]. 
As a result, due to the interactions within members of the same cell type as well as between cell 
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types that are vividly present in the 4-day co-culture model, we believe that it is the more 
representative 2D system of those that we developed and studied.  
Further modifications can be made to improve the 4-day culture. In this study, due to time 
restraints, changes were made to both time of introduction of cells and total co-culture time, 
without the characterization of controls in between. We hypothesize that EC islands are able to 
form because of the earlier introduction to the culture, and that a shorter culture time only reduces 
the background noise attributed to high cell density. However, we cannot rule out the possibility 
that EC islands may form early in the culture even when both cell types are introduced 
simultaneously but dissociate and experience EC death when culture time is prolonged. This could 
occur if the competition with EPs is for nutrients to maintain the island at later points in the culture 
when EPs are immensely more abundant rather than for time and space to form the island at the 
start of culture. We also cannot be sure that the reduced culture time does not diminish culture 
stability along with cell density, as the original rationale behind the 7-day culture was to allow for 
slowed proliferation and stabilization of the culture over time, much like the rationale behind the 
2-week 3D transwell co-cultures. It would thereby be important for future works to establish more 
controls in which only one variable is changed, including co-cultures in which (i) ECs are added a 
day prior to EPs and maintained for 7 days, and (ii) ECs and EPs are added simultaneously and 
maintained for 4 days.  
The 2D co-cultures we developed are a step forward in degree of physiological relevance 
from previous 2D culture models of the airway epithelium that only feature one cell type. Not only 
are we able to maintain both cell types in the culture, but we are also able to adequately visualize 
immunostaining for cell-specific protein markers to discern between cell phenotypes within our 
model. Thus, while it does not feature as many structural similarities to the airway as the 3D 
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transwell co-culture system which possesses an ALI across an epithelial cell layer maintain by an 
endothelial cell layer, the 2D culture presented preserves cellular interaction within and between 
cell types that are crucial in airway physiology. This defines it as a more robust and physiologically 
relevant model than previous single-cell type monolayers. Most importantly, in addition to the 
cellular interactions it retains, its ability to be observed via immunofluorescent imaging allows for 
the characterization of cellular morphological and phenotypic shifts in response to experimental 
conditions. These features place the 2D co-culture model ahead of the 3D transwell culture for use 
in in vitro models of airway disease progression and development, including fibrosis.  
 
TGFβ -Induced Fibrotic Type II EMT 
 Treatment of our less dense 4-day 2D co-culture system with TGFβ at higher 
concentrations (5 ng/mL) than that used in previous studies (2 ng/mL) demonstrates a prominent 
EMT-like phenotypic shift in epithelial cells. Using immunofluorescent staining assays for 
epithelial and mesenchymal cell markers, we are able to observe and characterize a seemingly 
step-wise progression of increasing EMT-induced change in epithelial cells across the co-culture 
models tested. Since all cultures were exposed to TGFβ for 48 hours only after a co-culture in 
regular growth medium was established, the combined effect of co-culture duration prior to 
induction and concentration of TGFβ added appears to determine degree of EMT progression. 
Cultures maintained for 7 days before treatment with lower concentrations of TGFβ present 
negligible differences [Figure 9A-B]. Similarly, 7-day cultures treated with higher concentrations 
of TGFβ show subtle increase in mesenchymal vimentin stain intensity, but not in FSP1 stain 
intensity [Figure 8A-D]. High background noise is apparent in both 7-day culture epithelial E-
cadherin stains, making comparisons in that channel more difficult. Staining for cytoskeletal actin 
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filaments with phalloidin likewise did not provide much insight on morphological changes due to 
the sheer volume of cell layers [Supplemental Figure 1]. On the other hand, 4-day cultures exposed 
to high concentrations of TGFβ depict the greatest degree of increase in mesenchymal vimentin 
stain intensity and clearly outline membranes with epithelial cell-surface E-cadherin stains [Figure 
8E-F]. Morphology can also be more clearly seen, although no stark differences are observed 
[Supplemental Figure 2].  
 Because we were able to visualize an incremental rise in mesenchymal marker intensity 
with an increased concentration of TGFβ and a reduced cell density, our model demonstrates 
multiple factors play a role in determining the scale of fibrotic development in vitro. Of the two 
mesenchymal markers tested, FSP1 specifically stained mesenchymal cells, although the number 
of cells stained seemed to decrease rather than increase in response to TGFβ, contrary to our 
hypothesis that mesenchymal markers would be expressed more with TGFβ treatment. The other 
marker, vimentin, a type III intermediate filament in mesenchymal cells, displays a more intense 
stain, but does not seem to be specific. Our data show that vimentin positively stains all cells in 
our controls and TGFβ-treated groups, suggesting that the intermediate filament is likely a protein 
that is globally expressed, but in greater amounts by mesenchymal cells. This lends to the 
possibility that all cells have the potential to acquire a mesenchymal-like phenotype in part because 
of their expression of these filaments, which further supports the idea that cell phenotypic shifts 
like EMT and MET take place along a continuum. That is, cells do not have to be only epithelial 
or only mesenchymal at a given time – rather, they can fall somewhere in between the two.  
 For our purposes of studying EMT, we were only interested in observing differences in 
epithelial and mesenchymal marker expression in our co-culture model. Endothelial cells were 
simply identified within the culture to ensure that both cell types remain present in the system 
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regardless of any external factors such as TGFβ or BMP7 added in downstream experiments. For 
instance, in the 4-day co-culture model, treatment with TGFβ or BMP7 did not disrupt the presence 
of EC islands within the co-culture [Supplemental Figure 2]. Previous studies we have conducted 
confirm that ECs also stain positively for vimentin (unpublished data). A control co-staining the 
system for endothelial CD31 and mesenchymal vimentin could be established to differentiate 
vimentin-positive ECs from EPs. Based on the findings of this control, a potential avenue of 
exploration our co-culture model allows for is the characterization the presence of mesenchymal 
markers in ECs in response to external factors, a process known as endothelial to mesenchymal 
transition (EndMT).  
 In developing a more physiologically relevant endothelial-epithelial cell co-culture model 
of fibrotic EMT induction, we have increased the complexity of the system in comparison to 
previous works that characterized EMT in single cell-type monolayers. In doing so, we have 
increased the number of factors and variables that must be accounted for. For instance, the presence 
of ECs in the co-culture may play a role in mediating the transition by promoting it or reducing it. 
As a result, it may be interesting to compare TGFβ-induced EMT in RBEPC monolayer cultures 
with that seen in the co-culture model described in this study to begin elucidating the role ECs 
play in directing EMT progression, if at all.  
 We are able to observe a dose-dependent graded progression of epithelial cell phenotypic 
shift caused by TGFβ-induced EMT across variations in our 2D culture model. In particular, a 7-
day culture with lower concentrations of TGFβ (2 ng/mL) did not demonstrate much change when 
compared to controls maintained in regular medium, while a 4-day culture with higher 
concentrations of TGFβ (5 ng/mL) displayed the greatest increase in mesenchymal marker 
intensity. Essentially, this can be interpreted as follows: lower concentrations of TGFβ introduced 
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to dense cell populations are less effective in inducing a net EMT phenotypic shift than higher 
concentrations of TGFβ introduced to less dense cell populations. This indicates that EMT can be 
induced in varying degrees within our model, as the phenotypic changes associated with TGFβ-
induced EMT vary depending on the experimental and environmental conditions. Thus, our co-
culture model of EMT-induction not only presents the opportunity to explore other factors such as 
EP-EC cell interactions in EMT progression but would also be useful in in vitro analyses 
characterizing the effectiveness of drugs and other factors like BMP7 on the development of 
fibrotic type II-EMT.  
 
BMP7 Treatment in Reducing EMT  
 After successfully inducing EMT in our co-culture model of the airway, we became 
interested in characterizing the effects of BMP7, a well-known antagonist of TGFβ-induced EMT, 
on ameliorating its progression in our system. While previous studies on renal proximal tubular 
epithelial cell cultures have demonstrated that treatment with BMP7 is able to reduce TGFβ-
induced EMT (Xu, Wan et al. 2009), we aimed to further develop our understanding of the 
interplay between these two factors by introducing them to our co-culture at various timepoints in 
the EMT induction process. If BMP7 is able to reduce TGFβ-induced EMT regardless of whether 
it is introduced to the system before, during, or after TGFβ is added, we expect heightened 
epithelial cell E-cadherin and reduced mesenchymal vimentin and FSP1 expression in comparison 
to cultures treated only with TGFβ. This was only the case in co-cultures treated with BMP7 48 
hours after treatment and was more apparent in the subset of those treated with higher 
concentrations of TGFβ [Figure 10]. As a result, we can conclude that the effectiveness of BMP7 
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treatment of fibrotic EMT phenotypic change is dependent on time of addition and concentration 
of TGFβ introduced to the culture.  
BMP7 treatment of fibrotic EMT in our co-culture model of the airway is only effective 
after TGFβ has been added and EMT has therefore already been induced. Pre-treating 7-day cell 
cultures with BMP7 48 hours prior to adding TGFβ and introducing the two simultaneously 
together into the culture for 48 hours does not bring about different phenotypes in comparison to 
TGFβ-only and medium-only controls cultures. Previous studies have demonstrated that the 
simultaneous treatment of other cell types like hepatocytes with both TGFβ and BMP7 has the net 
effect of reducing EMT progression (Zeisberg, Yang et al. 2007). However, it is apparent that in 
our model of the airway, BMP7 can neither reduce EMT progression in this manner, nor prevent 
cells from undergoing fibrotic development when added prior to induction. This suggests that the 
time-sensitive effectiveness of BMP7 in reducing TGFβ-induced EMT is also dependent on the 
tissue origin. In this way, some tissues may be more resilient to TGFβ-induced EMT if their 
phenotype is more readily returned towards an epithelial state at earlier stages of fibrotic 
development. Alternatively, the inability of simultaneous treatment with BMP7 and TGFβ to 
reduce phenotypic EMT shift may also be attributed to the presence of ECs within our co-culture.  
Despite the fact that it cannot reduce EMT phenotypic change when introduced before or 
during TGFβ addition, BMP7 displays this ability when added 48 hours after TGFβ-induced EMT. 
In these conditions, the intensity of mesenchymal intracellular vimentin staining is reduced 
alongside the number of cells stained positively for mesenchymal FSP1 not only in comparison to 
TGFβ-treated controls, but also to negative controls maintained in normal growth medium. These 
results suggest that when it is effective in reducing EMT in this co-culture system, BMP7 seems 
to overcompensate, and causes cells to display an even more epithelial-like phenotype than that 
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with which they began. Furthermore, this effect is more pronounced when treatment is initiated 
after high concentrations of TGFβ are added. The fact that BMP7 catalyzes the greatest degree of 
EMT reversal after cells have already progressed into a fibrotic state implies that it is more 
effective in reducing EMT phenotypic progression when it is more extensive and severe.  
 In this part of the study, we were limited to observing the phenotypic change introduced 
by adding BMP7 at various time points to 7-day co-culture models treated with various 
concentrations of TGFβ. Apart from observing more BMP7 controls co-culture conditions, our 
next step would be to characterize the effect of BMP7 introduced at different time points of EMT 
progression using the 4-day model presented, given its lower cell density leading to an improved 
image clarity and reduced background noise. Our data also only consists of qualitative 
immunofluorescent microscopy image analysis, as our attempts at quantifying the expression of 
cell-specific markers using flow cytometry failed. In preparation for this assay, our adherent cell 
lines were detached from the bottom of the tissue culture dish as cell sheets, but we were unable 
to adequately resuspend these cell sheets because they aggregated into one clump that could not 
be separated. Future endeavors to conduct flow cytometry on cells from this system may be more 
successful if cells are gently scraped off rather than trypsinized.  
For more quantitative data, a longitudinal analysis of cytokine concentrations within the 
co-culture medium could also provide a more in-depth understanding of the effects of and 
interactions between cytokines during EMT induction and reduction. Baseline TGFβ and BMP7 
levels can be established, from which we would be able to monitor the level of each cytokine 
during EMT progression and begin to answer questions regarding the balance between the two. 
For instance, we could determine whether each is broken down or secreted throughout EMT, as 
well as whether their concentrations are directly or inversely proportional to one another. With this 
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knowledge, we would be able to associate the phenotypic changes with underlying molecular 
differences in gene expression and cytokine secretion.  
Our 2D co-culture model enables us to study the phenotypic changes associated with the 
addition of factors like BMP7 on EMT progression within a more physiologically relevant in vitro 
representation of the airway. We found that BMP7 acts to reduce EMT-driven phenotypic shifts 
only when introduced after TGFβ and is not effective when administered prior to or at the start of 
induction. In addition, more reduction in mesenchymal cell markers is observed in conditions 
where cells are treated with high concentrations of TGFβ, suggesting that BMP7 is better at 
treating more severe cases of EMT progression. Under the conditions in which it is effective, 
BMP7 confers a heightened epithelial phenotype to affected cells such that they possess fewer 
mesenchymal markers even when compared to medium-maintained control cultures. Based on 
these data, we can conclude that BMP7 would likely be the most effective in treating fibrosis and 
does not prevent or reduce EMT progression when issued prior to fibrotic development. 
 
Conclusions 
 To improve our understanding of fibrosis, which underlies many airway diseases and 
complications, we have developed and characterized a novel in vitro model of the airway with 
improved physiological relevance over previous models. Our model successfully maintains two 
distinct cell types that are critical to airway physiology in a co-culture system: airway epithelial 
and blood vessel endothelial cells. It is across these cell layers that immune cells and inflammatory 
molecules pass when the airway experiences damage or trauma. This results in the signaling of 
fibrotic development through type II EMT, in which epithelial cells assume a more fibroblastic 
mesenchymal phenotype and promote the onset of disease. Thus, it is important that the 
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interactions between both cell types involved in coordinating this response be represented in our 
model.  
Co-cultures in both 3D transwell models and 2D models demonstrate that cells are able to 
interact with cells of the same and different type. Three-dimensional transwell co-cultures can 
support an ALI as early as 4 days into the co-culture, with medium-immersed ECs interacting with 
and maintaining air-exposed EPs on the opposite side of the membrane for the remainder of the 2-
week culture period. Individual ECs are dispersed throughout the 7-day 2D culture, which does 
not allow for interactions with other ECs. This is remedied in the 4-day culture, in which groups 
of ECs are able to form islands amidst EP networks. Of these models, we were only able to 
characterize TGFβ-induced EMT in the 2D co-culture, since the 3D model unsuccessfully 
immunostained for cell phenotype-specific protein markers. While our in vitro co-culture models 
of the airway can be used to study any relevant airway disease or phenomenon, we were interested 
in applying it to produce a model for fibrotic type II EMT induction and reduction. As a result, the 
best model presented by our study to characterize phenotypic shifts is the 4-day 2D co-culture 
model. For future investigations with different assays, the most physiologically relevant model is 
the 3D transwell co-culture.  
TGFβ induces an EMT-driven phenotypic shift in a dose-dependent manner, promoting the 
greatest degree of change when administered at a higher concentration to lower densities of cells 
in co-culture. Conversely, BMP7 is only effective in reducing EMT by promoting retention of an 
epithelial phenotype after EMT induction. BMP7 is most effective at reversing EMT after high 
concentrations of TGFβ, when more prominent EMT phenotypic shift has occurred. Thus, higher 
concentrations of TGFβ promote increased EMT, which is more effectively reduced by treatment 
post-fibrotic development with a given concentration of BMP7. According to our model, apart 
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from treatment after the induction of EMT, BMP7 has cannot be used as a preventative measure 
to reduce fibrosis before it arises. 
In this study, we describe a physiologically relevant co-culture model of the airway that 
can be used to model many phenomenon and diseases pertaining to those two cell types. We then 
demonstrate the ability of our system to model EMT-driven airway fibrosis and identify the effects 
of several added factors on disease progression. The successful implementation of this fibrotic 
EMT model not only improves our understanding of the roles of TGFβ and BMP7 on fibrotic 
development in the airway, but also implies that our co-culture system is versatile and can be 
applicable to other disease states. Further characterization of our model would therefore benefit 
research on understanding disease pathways or drug development for fibrosis. This model can also 
be extended to inform the development of other lung diseases. In doing so, the study of prevalent 
chronic diseases requiring lung transplantation, like COPD and IPF, as well as post-transplant 
complications, such as BOS, which are rooted in fibrosis, are only the beginning of a wider array 
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Supplemental Figure 1. Change in cell morphology cannot be determined in 7-day co-cultures. After 
7 days of EC/EP co-culture, BMP7 (100 ng/mL) was introduced at various time points of TGFβ-induced 
EMT (2 ng/mL). BMP7 was added (D) 48 hours before TGFβ, (E) simultaneously with TGFβ, or (F) 48 
hours after TGFβ. Control sample cultures were treated with (A) only media, (B) only TGFβ, or (C) only 
BMP7 at day 7 of co-culture and maintained for 48 hours. Immunostaining for cytoskeletal actin 
(phalloidin in red) and nuclei reveal a dense cell network from which individual cell morphology cannot 











Supplemental Figure 2. Endothelial cell islands persist in 4-day co-culture models treated with 
TGFβ or BMP7. After 4 days of EC/EP co-culture, (A) regular growth medium, (B) TGFβ (5 ng/mL) or 
(C) BMP7 (100 ng/mL) was added to the medium and cells were maintained for another 48 hours and 
then fixed, immunostained, and imaged. CD31-stained ECs (green) formed islands when allowed to grow 
in the culture system 24 hours before EPs were added at a 2:1 ratio (ECs: EPs) in all culture conditions. A 
shorter co-culture time of 4 days also resulted in reduced overall signal, as cells were not as densely 
layered (actin in red). Scale bars: 100 μm. 
 
